Beverly Hills, CA10 Active Studies

Essential Tremor Clinical Trials in Beverly Hills, CA

Find 10 actively recruiting essential tremor clinical trials in Beverly Hills, CA. Connect with local research sites and explore new treatment options.

10
Active Trials
8
Sponsors
14,377
Enrolling

Recruiting Essential Tremor Studies in Beverly Hills

RecruitingBeverly Hills, CANCT07064473

A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. ...

11,800 participants
Boehringer Ingelheim
View Study Details
RecruitingBeverly Hills, CANCT05099770

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-bio...

685 participants
Prokidney
View Study Details
RecruitingBeverly Hills, CANCT04108156

A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME

This study will evaluate the efficacy, safety, and Pharmacokinetics (PK) of the PDS with ranibizumab in participants with DME when treated every 24 weeks (Q24W) compared with intravitreal (IVT) ranibi...

634 participants
Hoffmann-La Roche
View Study Details
RecruitingBeverly Hills, CANCT04704921

Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

ABBV-RGX-314 (also known as RGX-314) is being developed as a novel one-time gene therapy for the treatment of neovascular (wet) age-related macular degeneration (wet AMD or nAMD). Wet AMD is character...

630 participants
AbbVie
View Study Details
RecruitingBeverly Hills, CANCT06321302

A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join the study. The purpose of this study is to find ou...

178 participants
Boehringer Ingelheim
View Study Details
RecruitingBeverly Hills, CANCT06116916

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with DME....

150 participants
Kyowa Kirin Co., Ltd.
View Study Details
RecruitingBeverly Hills, CANCT04514653

RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD) (AAVIATE)

RGX-314 is being developed as a potential novel one-time gene therapy treatment for the treatment of neovascular (wet) age related macular degeneration (wet AMD). Wet AMD is characterized by loss of v...

115 participants
AbbVie
View Study Details
RecruitingBeverly Hills, CANCT06770933

A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01

The goal of this clinical trial is to evaluate the efficacy, safety, pharmacokinetics (PK) and pharmacodynamics (PD) of VX-01 as stand-alone treatment for Diabetic Retinopathy of Non-Proliferative Typ...

100 participants
Vantage Biosciences Ltd
View Study Details
RecruitingBeverly Hills, CANCT06912633

Safety of a Single, Intravitreal Injection of 8.8M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)

This study evaluates the safety of a single injection of jCell (famzeretcel) comprising 8.8 million (8.8M) retinal progenitor cells over a six-month study period in a cohort of adult subjects with RP....

60 participants
jCyte, Inc
View Study Details
RecruitingBeverly Hills, CANCT05489523

Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With Transthyretin-mediated Amyloidosis Post Orthotopic Heart Transplantation

Transthyretin cardiac amyloidosis (ATTR-CA) is a relentlessly progressive disease that can progress to end stage heart failure, at which point recently approved transthyretin production silencing or s...

25 participants
University of Texas Southwestern Medical Center
View Study Details

About Essential Tremor Clinical Trials in Beverly Hills

Essential tremor is one of the most common movement disorders, causing involuntary shaking, most often in the hands. It is different from Parkinson's disease, though the two can be confused. Treatment includes medications, focused ultrasound, and deep brain stimulation for severe cases.

There are currently 10 essential tremor clinical trials recruiting participants in Beverly Hills, CA. These studies are seeking a combined 14,377 participants. Research is being sponsored by Boehringer Ingelheim, Prokidney, Hoffmann-La Roche and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Essential Tremor Clinical Trials in Beverly Hills — FAQ

Are there essential tremor clinical trials in Beverly Hills?

Yes, there are 10 essential tremor clinical trials currently recruiting in Beverly Hills, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Beverly Hills?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Beverly Hills research site will contact you about next steps.

Are clinical trials in Beverly Hills free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Beverly Hills studies also compensate for your time and travel.

What essential tremor treatments are being tested?

The 10 active trials in Beverly Hills are testing new therapies including novel drugs, biologics, and treatment approaches for essential tremor.

Data updated March 2, 2026 from ClinicalTrials.gov